HOLLY RABON: Open Payments
NPI 1114689791 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 64 payments from 15 companies in 2025. Trend: 2023 $1,702 · 2024 $1,647 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $236 |
| Kestra Medical Technology Services, Inc. | 20 | $224 |
| Novartis Pharmaceuticals Corporation | 9 | $205 |
| Abbott Laboratories | 4 | $194 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| BridgeBio Pharma, Inc. | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| CVRx, Inc. | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| PFIZER INC. | 2 | $47 |
Products named: Assure WCD, LEQVIO, FARXIGA, TRICLIP, WAINUA, JARDIANCE, CARDIOMEMS, Attruby.
Industry payments across NC — which companies pay providers there.
